Thyrotropin-releasing hormone
| thyrotropin-releasing hormone | |||||||
|---|---|---|---|---|---|---|---|
| Structural formula of TRH | |||||||
| Identifiers | |||||||
| Symbol | TRH | ||||||
| NCBI gene | 7200 | ||||||
| HGNC | 12298 | ||||||
| OMIM | 275120 | ||||||
| RefSeq | NM_007117 | ||||||
| UniProt | P20396 | ||||||
| Other data | |||||||
| Locus | Chr. 3 q13.3-q21 | ||||||
| 
 | |||||||
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.041.934 | 
| Chemical and physical data | |
| Formula | C16H22N6O4 | 
| Molar mass | 362.390 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Thyrotropin-releasing hormone (TRH) is a hypophysiotropic hormone produced by neurons in the hypothalamus that stimulates the release of thyroid-stimulating hormone (TSH) as well as prolactin from the anterior pituitary.
TRH has been used clinically in diagnosis of hyperthyroidism, and for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans. Its pharmaceutical form is called protirelin (INN) (/proʊˈtaɪrɪlɪn/).